$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

일개 한의의료기관에서 COVID 19 증상 완화를 위해 한약이 투여된 환자 63례에 대한 보고 : 후향적 차트 리뷰 연구
Reports of 63 Patients Treated with Herbal Medicine to Relieve Symptoms of COVID-19 at One Korean Medicine Clinic: A Retrospective Chart Review 원문보기

대한한방내과학회지 = The journal of internal Korean medicine, v.43 no.4, 2022년, pp.779 - 793  

김홍익 (정읍시 보건소, 고부보건지소) ,  윤종현 (일산 함소아 한의원) ,  추홍민 (파주시 보건소 월롱보건지소) ,  정세훈 (세종시 보건소) ,  이종훈 (일산 함소아 한의원) ,  김철현 (원광대학교 광주한방병원 한방내과) ,  신동길 ((주)함소아) ,  최혁용 ((주)함소아 제약) ,  조현주 ((주)함소아 제약) ,  이은경 ((주)함소아 제약)

Abstract AI-Helper 아이콘AI-Helper

Objectives: The purpose of this study was to report on the cases and prescriptions of non-face-to-face care performed to alleviate COVID-19 symptoms and to present their results. Methods: This study was conducted on 63 COVID-19 patients who visited the Ilsan Hamsoa Korean Medicine Clinic from Januar...

주제어

표/그림 (9)

참고문헌 (34)

  1. Ritchie H, Mathieu E, Rodes-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, et al. Coronavirus Pandemic (COVID-19). Our World in Data. Published March 5, 2020. Accessed September 19, 2021. https://ourworldindata.org/covid-vaccinations 

  2. Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 2021;27(2):225-8. doi:10.1038/s41591-020-1124-9 

  3. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 2020;383(27):2603-15. doi:10.1056/NEJMoa2034577 

  4. Kaur RJ, Dutta S, Bhardwaj P, Charan J, Dhingra S, Mitra P, et al. Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic Review. Indian J Clin Biochem. Published online March 27, 2021. doi:10.1007/s12291-021-00968-z 

  5. Jorgensen SCJ, Kebriaei R, Dresser LD. Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19. Pharmacother J Hum Pharmacol Drug Ther 2020;40(7):659-71. doi:10.1002/phar.2429doi:10.1002/ phar.2429 

  6. Ang L, Song E, Hu XY, Lee HW, Chen Y, Lee MS. Herbal Medicine Intervention for the Treatment of COVID-19: A Living Systematic Review and Cumulative Meta-Analysis. Front Pharmacol 2022;13:906764. doi:10.3389/fphar.2022.906764 

  7. Takayama S, Namiki T, Odaguchi H, Arita R, Hisanaga A, Mitani K, et al. Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials. Front Pharmacol 2021;12:1484. doi:10.3389/fphar.2021.656246 

  8. Jeon SR, Kang JW, Ang L, Lee HW, Lee MS, Kim TH. Complementary and alternative medicine (CAM) interventions for COVID-19: An overview of systematic reviews. Integr Med Res 2022; 11(3):100842. doi:10.1016/j.imr.2022.100842 

  9. Kwon SW, Lee WH, Jin C, Jang IS, Jung WS, Moon SK, et al. Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review. Integr Med Res 2020;9(3): 100480. doi:10.1016/j.imr.2020.100480 

  10. Kim DS, Chu HM, Min BK, Moon YJ, Park SJ, Kim KH, et al. Telemedicine Center of Korean Medicine for treating patients with COVID-19: a retrospective analysis. Integr Med Res 2020;9(3):100492. doi:10.1016/j.imr.2020.100492 

  11. Kim KH, Kang GH, Lee YU, Kang SN, Ji SH, Song JH, et al. Treating COVID-19 with Qingfei Paidu Decoction with and without Ephedra Herba: A Retrospective Case Series. J Intern Korean Med 2022;43(2):264-73. doi:10.22246/jikm.2022.43.2.264 

  12. Kang SW, Hong SE, Park JW, Kwon SW, Yoon SH, Kim KI, et al. Safety of Korean Medicine Treatment in Patients Vaccinated with the AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-19/AZD1222): A Case Series. J Intern Korean Med 2021;42(4):590-604. doi:10.22246/ jikm.2021.42.4.590 

  13. Kim JH, Ko WS, Yoon HJ. Bilateral Facial Palsy in a Patient with Guillain-Barre Syndrome after COVID-19 Vaccination. J Korean Med Ophthalmol Otolaryngol Dermatol 2022;35(1): 81-90. doi:10.6114/JKOOD.2022.35.1.081 

  14. Lee S, Park JE, Lee YJ, Kim SH, Lee JY. A Case Report of Taeeumin with Post COVID-19 Syndrome. J Sasang Const Med 2021;33(4): 32-42. doi:10.7730/JSCM.2021.33.4.32 

  15. Song JH, Park SY. A Case of Recurrent Herpes Zoster after Coronavirus Disease-2019 (COVID-19) Vaccination. J Korean Med Ophthalmol Otolaryngol Dermatol 2021;34(4): 181-97. doi:10.6114/JKOOD.2021.34.4.181 

  16. Kang B, Chu H, Youn BY, Leem J. Prevention and management of adverse events following COVID-19 vaccination using traditional Korean medicine: An online survey of public health doctors. World J Clin Cases 2022;10(28):10053-65. doi:10.12998/wjcc.v10.i28.10053 

  17. Micallef MJ, Iwaki K, Ishihara T, Ushio S, Aga M, Kunikata T, et al. The natural plant product tryptanthrin ameliorates dextran sodium sulfate-induced colitis in mice. Int Immunopharmacol 2002 Mar;2(4):565-78. 

  18. Lin H, Wang X, Liu M, Huang M, Shen Z, Feng J, et al. Exploring the treatment of COVID-19 with Yinqiao powder based on network pharmacology. Phytother Res. 2021; 35(5):2651-64. doi:10.1002/ptr.7012 

  19. Fan Y, Liu W, Wan R, Du S, Wang A, Xie Q, et al. Efficacy and safety of yinqiao powder combined with western medicine in the treatment of pneumonia: A systematic review and metaanalysis. Complement Ther Clin Pract 2021;42:101297. doi:10.1016/j.ctcp.2020.101297 

  20. Hong ND, Jeong GM, Moon JH, Joo SM. Studies on the Efficacy of Combined Preparation of Crude Drugs(XVII)-Effects of 'Bojungikgi-Tang' on the Digestive System, Blood Pressure and Diuretic Actions. Natural Product Sciences 1986; 17(3):223-31. 

  21. Lee JG, Koo YS, Lee YG, Park YC. Effect of Mahaenggamseok-tang-gagambang on CD3, CD4, CD8 Cells in OVA-induced Asthmatic Mice. Daejeon University Institute of Oriental Medicine 2008;17(1):67-74. 

  22. Hsieh CF, Lo CW, Liu CH, Lin S, Yen HR, Lin TY, et al. Mechanism by which ma-xingshi-gan-tang inhibits the entry of influenza virus. J Ethnopharmacol 2012;143(1):57-67. doi:10.1016/j.jep.2012.05.061 

  23. Lin SK, Tsai YT, Lo PC, Lai JN. Traditional Chinese medicine therapy decreases the pneumonia risk in patients with dementia. Medicine (Baltimore) 2016;95(37):e4917. doi:10.1097/MD.0000000000004917 

  24. Wang C, Cao B, Liu QQ,, Zou ZQ, Liang ZA. Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan-Yinqiaosan in the Treatment of H1N1 Influenza. Ann Intern Med 2011;155(4):217-25. doi:10.7326/0003-4819-155-4-201108160-00005 

  25. Jeong SH. A study on the anti-inflammatory action of Gagamgalgeunhaegi-tang. [master's thesis]. Daejeon, South Korea, Daejeon University of Korean Medicine 2004. 

  26. Woo JS. Effects of Galgun Hegi Tang on Immune Response in Mouse. J Korean Med 1990;11(2):436-57. 

  27. Kim HK, Shin SW, Park JH. Inhibitory effect of Galgeunhaeji-Tang on compound 48/80 stimulated allergic reaction. Korean J Oriental & Pathology 2009;23(2):381-8. 

  28. Li XM, Srivastava K. Traditional Chinese medicine for the therapy of allergic disorders. Curr Opin Otolaryngol Head Neck Surg 2006; 14(3):191-6. doi:10.1097/01.moo.0000193199.40096.f7 

  29. Kamei J, Nakamura R, Ichiki H, Kubo M. Antitussive principles of Glycyrrhizae radix, a main component of the Kampo preparations Bakumondo-to (Mai-men-dong-tang). Eur J Pharmacol 2003;469(1-3):159-63. doi:10.1016/S0014-2999(03)01728-X 

  30. Kim H, Jeong HS, Kwon J, Lee KG. Effect of Maekmoondong-tang on the Immunomodulatory action. Korean J Oriental & Pathology 2003;17(4):946-51. 

  31. Kim HW, Yang SY, Kim MH, Nam GW, Park YC. Protective Effects of Maekmundong-tang on Elastase-induced Lung Injury. J Korean Orient Med 2011;32(2):63-78. 

  32. Jin ZY, Wang HH. Efficacy evaluation of Yinqiaosan and Zhuyegyaotang in adjuvant treatment of patients with severe pneumonia with the same syndrome of Wei and Qi. The clinical Research 2021;4:115-6. 

  33. The association of Korean Medicine. Coronavirus Infectious Disease-19 Korean Medicine Treatment Recommendation. Vol 1. 2nd edition. Seoul: The association of Korean Medicine; 2020. 

  34. Kim TH. Herbal medicines for fatigue or brain fog in Coronavirus disease 2019 (COVID-19) survivors: a prospective pilot clinical study. [cited 3 July 2022]. Available from: https://cris.nih.go.kr/cris/search/detailSearch.do/20001. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로